In this issue:
ARMANI: Early switch maintenance for HER2-negative GEJ cancer
Preoperative CRT vs chemotherapy for GEJ adenocarcinoma
Futibatinib for FGFR2 amplified gastric or GEJ cancer
Could FEM improve detection of dysphasia in Barrett’s oesophagus?
Preclinical evaluation of an armoured CLDN18.2-targeted CAR T-cell therapy
NEXUS-1: survival benefit to triplet conversion therapy in unresectable OSCC
Oesophageal cancer tumour budding is associated with poor prognosis
Early recurrence of GEJ adenocarcinoma after neoadjuvant FLOT
Should diagnostic laparoscopy be used in Siewert II GEJ cancer?
Sequencing of chemotherapy and concurrent CRT for OSCC
Please login below to download this issue (PDF)